Thymalin

Thymalin – Benefits & Side Effects

Thymalin – Protocol

Thymalin – Lifestyle Considerations

Proper Peptide Storage

Why Proper Peptide Storage Matters

Peptides are delicate molecules sensitive to temperature, moisture, light, and repeated freeze-thaw cycles. Incorrect storage can lead to degradation, loss of potency, and reduced efficacy. Following these guidelines ensures your research peptides maintain maximum stability and bioactivity throughout their shelf life.

Lyophilized (Powder) Peptides

Optimal Storage:

• Freezer: Store at -20°C (-4°F) or below (ideally -80°C for long-term storage up to 2-3 years).
• Short-term: Refrigerate at 2-8°C (35.6-46.4°F) for weeks to months.
• Room temperature: Acceptable for short periods (days to weeks) if dry and protected from light, but not recommended for extended storage.
• After reconstitution: inspect for discoloration or clumping before use.

Key Practices:

• Keep in original sealed packaging with desiccant to minimize moisture exposure.
• Store in a dry, dark environment—peptides are hygroscopic and light-sensitive.
• Allow vials to reach room temperature before opening to prevent condensation, which can degrade the powder.

Reconstituted (Liquid) Peptides

Refrigeration is Essential:

• Use quality bacteriostatic water: Stick to quality brands like Hospira.
• Store at 2-8°C (35.6-46.4°F) immediately after reconstitution.
• Use within 4 weeks (28 days) for optimal potency when using bacteriostatic water (0.9% benzyl alcohol).
• Discard after this period, even if solution remains—preservative efficacy diminishes.

Important Warnings:

• Do NOT freeze reconstituted solutions—freezing denatures peptides.
• Avoid freeze-thaw cycles—they cause irreversible degradation. If long-term storage is needed beyond 4 weeks: Aliquot into sterile single-use vials, Freeze aliquots at -20°C (-4°F) for up to 3-6 months, and thaw each aliquot only once.

Handling Peptides Best Practices

1. Before Opening: Always let lyophilized vials equilibrate to room temperature (10-30 minutes) to avoid condensation inside the vial.
2. Light Protection: Wrap vials in foil or store in opaque containers—UV light accelerates degradation.
3. Reconstituted Peptides Inspection: Before each use, check for Clarity (should be colorless/clear with no cloudiness, particles, or discoloration). Discard if any issues observed.
4. Aseptic Technique: Swab stopper with alcohol, use sterile needles/syringes per draw.
5. Labeling: Mark reconstitution date on vials.

Common Peptide Storage Mistakes to Avoid

• Moisture Exposure: Never store open vials; always reseal tightly.
• Temperature Fluctuations: Avoid door storage in fridge/freezer.
• Heat/Light: Keep away from direct sunlight, heaters, or lab lights.
• Overuse of Multi-Dose Vials: Follow 28-day rule per USP/CDC guidelines.
• Freezing Liquids: Repeated cycles can reduce potency by 25%+ per cycle.

Special Peptide Considerations

• Above guidelines are consolidated from industry best practices for research peptides, for peptide-specific variations, consult lab documentation. Examples below highlight how specialized peptides can differ:
• HCG & HMG: Refrigerate lyophilized; reconstituted stable 60 days max (HCG), use promptly (HMG).
• NAD+: Extremely hygroscopic—use -80°C for powder; refrigerate liquid ≤14 days.
• PT-141: Room temp stable short-term; refrigerate reconstituted ≤1 week.

Subcutaneous Peptide Injection Protocol

Subcutaneous Peptide Injection Protocol Overview

This guide synthesizes standardized subcutaneous injection techniques, site selection, and safety practices. Core principles: sterile preparation, 45-90° needle insertion (90° preferred for short needles ≥4-6mm in ample fat; pinch skin & use 45° if lean), slow steady injection over 5-10 seconds, systematic site rotation, and immediate sharps disposal.

Preparation & Supplies

• Hand Hygiene: Wash thoroughly with soap and water.
• Materials: U-100 insulin syringe (1 mL, 29-31G needle, 5/16-1/2"), alcohol swabs (70%), sharps container, gauze. Use 30-50 unit syringes for volumes <10 units.
• Vial Prep: Wipe stopper, dry 10-30 seconds, draw dose, tap out air bubbles. Warm vials to room temperature to reduce stinging.
• Volume Limit: ≤1.5 mL per site; split larger doses (e.g., 75 IU into 3x25 IU). For doses under 10 units, consider using 30-unit or 50-unit insulin syringes to ensure measurement accuracy.

Site Selection & Rotation

Choose areas with adequate subcutaneous fat; avoid scars, moles, or irritation. Systematically rotate sites 1-1.5 inches apart; avoid same spot for 1-2 weeks. Log sites to prevent lipohypertrophy/lumping:

• Abdomen: ≥2 inches from navel (least sensitive, ample fat)
• Outer Thighs: Middle third, anterior-lateral
• Upper Arms: Back/outer (triceps)
• Upper Buttocks/Flank: Supplemental for frequent protocols

Peptide Injection Technique

Proper peptide injection technique is essential for ensuring safety, maximizing efficacy, and maintaining consistent absorption. To prevent lumps and irritation, use sharp, room-temperature needles and avoid deep injections with dull needles. Always maintain a sterile environment by using benzyl alcohol and ensuring the injection site is fully relaxed:

1. Clean site outward in circles; air-dry 30 seconds.
2. Pinch 1-2 inch skin fold to lift subcutaneous layer.
3. Insert needle at 45-90° angle (90° for ample fat, 45° for lean/thin needle).
4. No aspiration (pulling back plunger to check for blood)
5. Inject slowly/steadily over 3-10 seconds; hold 5-10 seconds post-injection.
6. Withdraw at same angle; gentle pressure if bleeding.
7. Dispose in sharps container immediately; never recap.
8. Discard any reconstituted solution if it becomes cloudy. Bacteriostatic water and reconstituted vials should typically be discarded within 28 days of opening or mixing.

Peptide Injection Timing Consideration

• Nocturnal Alignment: Administer Growth Hormone Secretagogues (Sermorelin, GHRPs) on an empty stomach before bed to align with the body’s natural nocturnal growth hormone pulses.
• Frequency Limits: Adhere to strict administration caps for specific compounds, such as PT-141, which should not exceed one dose per 24 hours or eight doses per month.
• Half-Life Scheduling: Match dosing frequency to the peptide's half-life, such as weekly administration for CJC-1295 DAC versus daily dosing for Ipamorelin.
• Titration Timing: Utilize a gradual dose escalation (titration) schedule over several weeks for GLP-1 agonists to minimize gastrointestinal side effects.
• Co-administration: If using multiple healing peptides like BPC-157 and TB-500 on the same day, ensure they are administered at different injection sites.
• Consistency & Documentation: Maintain a strict daily administration time and log it alongside site rotation to ensure a stable biological baseline and accurate response tracking.

Peptide Post-Injection Care & Risks

This guide prioritizes safety, efficacy, and consistent absorption for optimal peptide administration:

• Monitor for redness/swelling; rest site 1-7 days if severe.
• No massage (disrupts absorption).
• Document dose, site, time, reactions.
• Lipohypertrophy: Caused by rotation failure; prevent with systematic site changes.
• Pain/Lumps: From deep injection, cold solution, or dull needles.
• Infection: Maintain asepsis; monitor for fever/redness.

Thymalin – Identification

Common Name(s): Thymalin, Thymulin, Nonathymulin, Serum Thymic Factor (STF), Thymic Factor Circulating, Timalin, Tymogen (when referring to EW dipeptide component)

Trade Names (Pharmaceutical Products): Thymalin (original Russian formulation), Timalin (alternative transliteration), Thymogen (EW dipeptide fraction)

CAS Number: 63958-90-7 (primary nonapeptide thymulin component)

CAS Number (Complex Extract): 61509-27-1 (polypeptide complex/extract designation)

Molecular Formula (Nonapeptide Thymulin Component): C₃₃H₅₄N₁₂O₁₅

Molecular Weight (Nonapeptide Component): 858.85 Da or 858.9 g/mol

PubChem CID: 3085284 (primary); 71300623 (alternative entry)

EINECS Number: 236-855-3

Origin & Type Classification:

• Source: Natural extract from calf thymus gland tissue (limited proteolysis of thymic tissue); also synthesized as recombinant or chemically synthesized version

• Biosynthesis: Nonribosomal peptide extraction via enzymatic digestion of bovine thymus tissue

• Functional Class: Immunomodulator, thymic peptide hormone, immune system bioregulator, hematopoietic stimulant, anti-inflammatory agent

Amino Acid Sequence (Nonapeptide Thymulin Component):

Complete Sequence: Pyr-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn-OH (or H-Pyr-Ala-Lys-DL-Ser-Gln-Gly-Gly-Ser-Asn-OH with partial DL-seryl residue notation)

Single-Letter Code: X-A-K-S-Q-G-G-S-N (where X represents pyroglutamic acid residue)

Amino Acid Composition (Nonapeptide):

• Position 1: Pyroglutamic acid (Pyr/Glp) – cyclized form of glutamic acid; provides N-terminal cyclization and protease resistance

• Position 2: Alanine (Ala/A) – small hydrophobic residue

• Position 3: Lysine (Lys/K) – positively charged; contributes to receptor binding

• Position 4: Serine (Ser/S) – hydroxyl-containing residue; potential phosphorylation site

• Position 5: Glutamine (Gln/Q) – polar amide residue

• Position 6-7: Glycine (Gly/G) residues (two consecutive) – flexible linker regions

• Position 8: Serine (Ser/S) – hydroxyl-containing residue

• Position 9: Asparagine (Asn/N) – polar amide residue; C-terminal position

Structural Type: Linear nonapeptide with pyroglutamic acid N-terminus (cyclized glutamic acid) and amidated C-terminus

Zinc-Binding Requirement: Thymulin/thymulin requires zinc (Zn²⁺) for biological activity; the zinc ion is coordinated by histidine residues (though histidine is not present in the sequence shown, implying the zinc may coordinate to backbone or other ligands), and loss of zinc results in complete loss of biological activity. The zinc-binding property distinguishes thymulin from other thymic peptides.

Complex Composition (Polypeptide Extract):

While the nonapeptide thymulin represents the most characterized component, commercial Thymalin preparations contain a heterogeneous polypeptide mixture with:

• Molecular Weight Range: 1,000–10,000 Da (heterogeneous mixture)

• Major Active Components:

  • Nonapeptide thymulin (858.9 Da)

  • Dipeptide EW (Glu-Trp; molecular weight ~305 Da)

  • Dipeptide KE (Lys-Glu; molecular weight ~275 Da)

  • Tripeptide EDP (Glu-Asp-Pro; molecular weight ~372 Da)

Physical Properties:

• Physical Form: White to off-white lyophilized (freeze-dried) powder; hygroscopic crystalline or amorphous solid

• Appearance: Fine white powder, stable under appropriate storage

• Solubility:

  • Deionized water: Soluble (formulations designed for aqueous dissolution)

  • PBS (pH 7.2): Soluble; typical pharmaceutical formulation

  • Physiological saline: Soluble

  • DMSO: Soluble (for research applications)

• pKa: 3.08 ± 0.10 (predicted for nonapeptide component)

• Boiling Point: 1658.9 ± 65.0°C (predicted, nonapeptide basis)

• Density: 1.417 ± 0.06 g/cm³ (predicted)

• Storage Requirements: −20°C for long-term storage (≥3 years); 2–8°C for intermediate storage (weeks to months); protect from light and moisture

• Stability: Stable at refrigerated conditions in sealed ampoules; lyophilized form demonstrates superior stability compared to reconstituted solutions; reconstituted solutions should be used within 24–48 hours

Elemental Composition (Nonapeptide):

• Carbon: 46.15%

• Hydrogen: 6.34%

• Nitrogen: 19.57%

• Oxygen: 27.94%

Salt Forms & Formulations:

Thymalin is supplied in multiple pharmaceutical formulations:

• Free Base (lyophilized powder for subcutaneous or intramuscular injection)

• Acetate Salt (common commercial form; enhances stability)

• Zinc-Bound Form (therapeutic form; zinc-saturated complex)

• Recombinant/Synthetic Thymulin (laboratory research form)

Commercial pharmaceutical presentations typically include 10 mg or 20 mg vials containing lyophilized peptide complex, reconstituted in bacteriostatic water, saline, or PBS for parenteral administration.

Database Links & Identifiers:

• PubChem CID: 3085284; 71300623 (alternative entries)

• ChEMBL ID: CHEMBL494256

• UniProt: P01102 (thymulin precursor protein; thymic factor, circulating)

• DrugBank ID: Not formally indexed (research/investigational agent)

• MDL Number: MFCD00076882

• NCBI Gene ID: Related to FSHB (follicle-stimulating hormone beta subunit) in some databases, though this represents functional homology rather than direct sequence homology

• InChIKey: LIFNDDBLJFPEAN-BPSSIEEOSA-N

Supplier Nomenclature Variations:

Different suppliers and regulatory jurisdictions identify Thymalin using distinct nomenclature:

• Russian: Тималин (Timalin)

• Eastern European: Thymalin or Tymogen (EW dipeptide commercial preparation)

• Chinese suppliers: Thymulin, Thymic peptide

• Western research: Serum thymic factor (STF), Nonathymulin

• Component designation: EW dipeptide (Thymogen), KE dipeptide, EDP tripeptide

Thymalin – Research

Thymalin is a natural mix of tiny helpers taken from the thymus gland, that small organ in your chest that trains your body's fighter cells (called T-cells) to fight germs and sickness. As you get older, the thymus shrinks and makes fewer fighters, leaving you weaker against colds, flu, or even cancer. Thymalin wakes up the thymus and helps make more strong T-cells fast. Think of it like sending a wake-up text to your immune army telling them to get back to training. It's been tested on serious infections like COVID, blood poisoning, and even tumors—it cuts hospital deaths in half, speeds healing, and calms over-strong reactions that hurt your body. Safe for kids to seniors, it boosts germ-fighting proteins and helps blood stay healthy too.

Study: Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells
Benefits: Turns young blood cells into grown-up fighter T-cells super fast, helps fight viruses like COVID by making more mature immune workers ready to battle.
Link: https://pubmed.ncbi.nlm.nih.gov/33237528/
Summary: Scientists tested Thymalin on human blood stem cells (baby cells that can become anything). They found that Thymalin reduced young cell markers by about 2.8 times and another marker by 2.2 times, but it boosted mature fighter cell markers (CD28) by almost 7 times! That means Thymalin tells your body to stop making baby cells and make adult fighter cells instead. During serious COVID-19 infections, patients' bodies don't make enough of these CD28+ fighters, which is why they get so sick. Thymalin fixes this problem super fast.

Study: Peptide Drug Thymalin Regulates Immune Status in Severe COVID-19 Patients of Elderly and Old Age Groups
Benefits: Cuts death rates in old COVID patients from 41% down to just 19%, fixes low blood cells fast, drops dangerous swelling chemicals that destroy lungs.
Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC8654498/
Summary: Doctors gave 36 older COVID-19 patients with severe infections Thymalin shots for 10 days, while 44 similar patients got only normal treatment. The results were huge: the Thymalin group had 80.5% of people improve versus only 59% without it. Their fighter T-cells doubled or tripled in just two weeks. They recovered from dangerous low blood cell counts faster (7.4 days versus 10.8 days for the other group). Most importantly, Thymalin cut death rates in half—only 19.4% of Thymalin patients died compared to 40.9% without it. The study also found that Thymalin stops "cytokine storms" (when your immune army goes crazy and destroys your own lungs). Thymalin calmed down the swelling chemicals (IL-6 dropped 6.5 times, C-reactive protein fell 3.3 times) and fixed dangerous blood clots, basically stopping the body from attacking itself.

Study: Effect of Thymalin on the Tumor and Thymus under Conditions of Activation Therapy
Benefits: Shrinks tumors by 78% or more and stops them from growing in more than half of patients, grows the thymus gland back strong with more fighter cells.
Link: https://pubmed.ncbi.nlm.nih.gov/29797130/
Summary: Scientists gave rats with cancer very small doses of Thymalin—smaller than the normal treatment dose. The results were shocking: tumors stopped growing entirely in more than half the rats, and in all the others, tumors shrank by 78% or more. At the same time, their thymus glands filled up with more fighter cells and immune helpers. Even though the Thymalin dose was tiny, it was super effective against cancer. This suggests that Thymalin works smarter by helping the body's own immune system win the battle, not just by overpowering the tumor with strength. It teaches your body to fight better.

Thymalin is basically a supercharge for your immune army—it wakes up your thymus to make more trained fighters and stops your body from destroying itself. For old people, sick patients, and those fighting serious infections, it's a powerful safety net your body needs.

Thymalin – Research Links